| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 46 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 46 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 46 |
| 3 | TACROLIMUS | 42 |
| 4 | METHOTREXATE SODIUM | 37 |
| 5 | ACETAMINOPHEN | 35 |
| 6 | METHOTREXATE | 34 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 34 |
| 8 | TACROLIMUS OINTMENT 0.1% | 34 |
| 9 | ACETAMINOPHEN 500MG | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM DIHYDROGEN PHOSPHATE | 1 | 0.0345 |
| 1 | AGING CHEST AND NECK RESCUE TREATMENT CREAM | 2 | 0.0225 |
| 2 | BRINCIDOFOVIR | 1 | 0.0072 |
| 3 | CETYLPYRIDINIUM CHLORIDE | 3 | 0.0046 |
| 4 | DEXRAZOXANE FOR INJECTION | 3 | 0.0032 |
| 5 | INTERLEUKIN-10 | 1 | 0.0028 |
| 6 | MEGNESIUM OXIDE | 1 | 0.0024 |
| 7 | CLOFARABINE | 5 | 0.0022 |
| 8 | VINBLASTINE SULFATE | 4 | 0.0020 |
| 9 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 4 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 86 |
| 1 | Alkylating Drug [EPC] | 72 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 45 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 44 |
| 4 | Azole Antifungal [EPC] | 36 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 35 |
| 6 | Benzodiazepine [EPC] | 32 |
| 7 | Osmotic Laxative [EPC] | 30 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 27 |
| 9 | Proton Pump Inhibitor [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 4 | 0.0016 |
| 1 | Lymphocyte Growth Factor [EPC] | 2 | 0.0016 |
| 2 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 8 | 0.0009 |
| 5 | Osmotic Diuretic [EPC] | 4 | 0.0008 |
| 6 | Lipid Emulsion [EPC] | 2 | 0.0008 |
| 7 | Asparagine-specific Enzyme [EPC] | 10 | 0.0007 |
| 8 | Cannabinoid [EPC] | 6 | 0.0007 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 14 | 0.0007 |